These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effect of 1,25 dihydroxyvitamin D3 and calcium on growth and differentiation and on c-fos and p53 gene expression in normal human keratinocytes. Sebag M; Gulliver W; Kremer R J Invest Dermatol; 1994 Sep; 103(3):323-9. PubMed ID: 8077697 [TBL] [Abstract][Full Text] [Related]
29. Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation. Glade CP; van Erp PE; van Hooijdonk CA; Elbers ME; van de Kerkhof PC Acta Derm Venereol; 1995 Sep; 75(5):381-5. PubMed ID: 8615058 [TBL] [Abstract][Full Text] [Related]
31. PPAR gamma is an important transcription factor in 1 alpha,25-dihydroxyvitamin D3-induced involucrin expression. Dai X; Sayama K; Shirakata Y; Tokumaru S; Yang L; Tohyama M; Hirakawa S; Hanakawa Y; Hashimoto K J Dermatol Sci; 2008 Apr; 50(1):53-60. PubMed ID: 18077140 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of and response to 1,25 dihydroxycholecalciferol by subpopulations of murine epidermal keratinocytes: existence of a paracrine system for 1,25 dihydroxycholecalciferol. Rizk-Rabin M; Zineb R; Zhor B; Michèle G; Jana P J Cell Physiol; 1994 Apr; 159(1):131-41. PubMed ID: 8138581 [TBL] [Abstract][Full Text] [Related]
34. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells. Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190 [TBL] [Abstract][Full Text] [Related]
35. Immunosuppressive effects of 1,25-dihydroxyvitamin D3 and its analogue calcipotriol on epidermal cells. Bagot M; Charue D; Lescs MC; Pamphile RP; Revuz J Br J Dermatol; 1994 Apr; 130(4):424-31. PubMed ID: 8186106 [TBL] [Abstract][Full Text] [Related]
36. Regulation of metallothionein gene expression by 1 alpha,25-dihydroxyvitamin D3 in cultured cells and in mice. Karasawa M; Hosoi J; Hashiba H; Nose K; Tohyama C; Abe E; Suda T; Kuroki T Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8810-3. PubMed ID: 3480513 [TBL] [Abstract][Full Text] [Related]
37. Retinoic acid modulates the anti-proliferative effect of 1,25-dihydroxyvitamin D3 in cultured human epidermal keratinocytes. Segaert S; Garmyn M; Degreef H; Bouillon R J Invest Dermatol; 1997 Jul; 109(1):46-54. PubMed ID: 9204954 [TBL] [Abstract][Full Text] [Related]
38. Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin. Abe J; Kondo S; Nishii Y; Kuroki T J Clin Endocrinol Metab; 1989 Apr; 68(4):851-4. PubMed ID: 2921314 [TBL] [Abstract][Full Text] [Related]
39. 1 alpha,25-dihydroxyvitamin D3 inhibits normal human keratinocyte growth by increasing transforming growth factor beta 2 release. Haugen JD; Pittelkow MR; Zinsmeister AR; Kumar R Biochem Biophys Res Commun; 1996 Dec; 229(2):618-23. PubMed ID: 8954947 [TBL] [Abstract][Full Text] [Related]
40. Suppression of proliferation of human epidermal keratinocytes by 1,25-dihydroxyvitamin D3. Analysis of its effect on psoriatic lesion and of its mechanism using human keratinocytes in culture. Kitano Y; Ikeda N; Okano M Eur J Clin Invest; 1991 Feb; 21(1):53-8. PubMed ID: 1907555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]